Navigation Links
Waters Introduces the SYNAPT G2-Si to Its Mass Spectrometer Product Line

MINNEAPOLIS, June 10, 2013 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today unveiled the new Waters® SYNAPT® G2-Si Mass Spectrometer at the 61st conference of the American Society of Mass Spectrometry (ASMS). The company is also previewing its UNIFI® CCS Research Edition and the new TransOmics Version 2.0 informatics products for the new SYNAPT G2-Si mass spectrometer and demonstrating their benefits for a variety of small molecule applications and cutting-edge Omics-focused research.

(Logo: )

The SYNAPT G2-Si System integrates a third dimension of resolution and separation power into a new suite of untargeted and targeted LC/MS/MS workflows. This powerful new tool gives researchers a means with which to gain a deeper understanding of molecular biology and disease mechanisms, to develop the next generation of healthcare treatments or chemical materials, or to screen food products or environmental samples for contaminants. SYNAPT G2-Si now combines the unique power of Travelling Wave (T-Wave) Ion Mobility Separations with new data acquisition and informatics technologies, and collision cross section (CCS) measurements to bring to the toughest analytical applications, unparalleled information and confidence at a level not possible by mass and chromatographic separation alone.

The SYNAPT G2-Si mass spectrometer is the first MS system to elevate CCS alongside retention time and mass to charge ratio (m/z) as a robust, reliable identification parameter in library-based screening.

"CCS measurements have the potential to transform the way people screen for known compounds, because unlike parameters like retention time, CCS values are unaffected by different matrices and chromatographic methods, and give you a much higher level of confidence that you found what you're looking for," said Dr. Severine Goscinny, Belgium Scientific Institute for Public Health, Brussels, Belgium. "The SYNAPT G2-Si system exemplifies Waters continuing commitment to innovation in mass spectrometry and collaborating with researchers on their journey of exploration."

The collision cross section of a molecule is an important distinguishing feature that is directly related to its chemical structure and three-dimensional conformation in the gas-phase. Like molecular mass, this additional orthogonal property of a molecule (through the use of high-efficiency T-wave ion mobility technology) gives scientists increased coverage and clarity for profiling mixtures or gaining additional measurements with which they can investigate chemical structures or better confirm a molecule's identity.

Integrating separation by CCS into targeted and untargeted experiments through new high-definition data-directed-analysis (HD-DDA) and high definition multiple reaction monitoring (HD-MRM) modes brings compelling benefits to the most challenging qualitative and quantitative applications.

  • Maximized time-of-flight (Tof) duty cycle and effective sensitivity - of up to 10x in MS/MS mode - for targeted discovery and quantitation
  • Improved LC/MS/MS efficiency with a 40% improvement in the numbers of proteins identified from an E. coli sample and the identification of more than 2,000 proteins from a HeLa sample
  • Routine ultra-sensitive MS/MS assays with the benefit of high resolution and accurate mass for targeted quantification experiments
  • Physical separation of interferences away from the molecule or transition of interest on the basis of their collision cross section for improved selectivity when working with very complex matrices.
  • A new and faster 2.5KHz solid state laser combined with new software for improved spatial resolution (down to 15 microns) for cleaner mass spectral data and greater image throughput when performing experiments with MALDI imaging and T-wave ion mobility

As evidence of the successful use of T-Wave ion mobility mass spectrometry for the research laboratory, the International Journal of Ion Mobility Spectrometry in February of this year published an exclusive, two-volume special edition series on T-Wave ion mobility featuring 13 scientific articles by some of the world's top scientists.

As the newest member of the SYNAPT family of mass spectrometers, the SYNAPT G2-Si system can separate individual isomers, conformers, and isobaric compounds; help determine sites of biotransformation; study structure at physiological concentrations; comprehensively profile complex mixtures and minimize false positives and negatives in screening experiments.

For more information:

Waters Enhances its Omics Research Platform Solution with TransOmics 2.0 Informatics

At ASMS Waters is previewing an enhanced range of Omics Research Platform Solutions, powered by TransOmics™ 2.0 Informatics.  The new TransOmics 2.0 informatics packages for proteomics and metabolomics/lipidomics, created exclusively for Waters by its strategic business partner Nonlinear Dynamics (Newcastle upon Tyne, UK), are based on extended versions of the Nonlinear Dynamics Progenesis™ LC-MS and CoMet products.  The TransOmics 2.0 informatics packages are specifically designed to process and visualize SYNAPT High Definition Mass Spectrometry (HDMS) Omics data, denominated with Collision Cross Section (CCS), from the new Waters SYNAPT G2-Si HDMS mass spectrometer.

Proteomics, metabolomics and lipidomics researchers routinely acquire large, content-rich, data sets that need to be efficiently reduced and intuitively visualized to facilitate the extraction of biologically significant results. TransOmics 2.0 has been developed specifically to address these issues and reveal the potential of CCS denominated Omics data.

University of Washington Researcher, Matthew F. Bush, to Receive ASMS Research Award Sponsored by Waters Corporation

On Tuesday, June 11, Dr. Matthew Bush of the University of Washington will receive the 2013 ASMS Research Award sponsored by Waters Corporation in recognition of his research on intact protein complexes using mass spectrometry. The award, which comes with a cash prize of $35,000, is being awarded to Dr. Bush for his laboratory's research into developing and applying fast and sensitive mass spectrometry techniques for characterizing biological assemblies. This is the 27th year of award sponsorship by Waters Corporation.

About Waters Corporation (

For more than 50 years, Waters Corporation has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, SYNAPT and UNIFI are trademarks of Waters Corporation. TransOmics and Progenesis are trademarks of Nonlinear Dynamics.

SOURCE Waters Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
2. Waters Breaks Ground on New Mass Spectrometry HQ in Wilmslow, UK
3. Fera and Waters Open International Food Safety Training Laboratory
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. Waters and DANI Instruments Announce Integrated and Compatible Network
6. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
7. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
8. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
9. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
10. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
11. IDEV Technologies Introduces SurePath™ Guidewires
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):